A first in human, open-label, multicenter Study of VOR33 in patients with Acute Myeloid Leukemia who are at High-Risk for Leukemia Relapse Following Hematopoietic Transplant.

Brief Summary

Type:
Leukemias

Study Type:

Phase:

ClinicalTrials.gov Identifier:

Study #:
VOR Biopharma 101 (VBP101)

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID:

View Complete Trial Details & Eligibility at ClinicalTrials.gov